Edges in Network
Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
Node | ELAVL3 |
Upstream (Parents) |
---|
(<<) SIGLEC6 → ELAVL3 |
(<<) EPB41L3 → ELAVL3 |
(<<) GKN1 → ELAVL3 |
(<<) EMILIN2 → ELAVL3 |
(<<) DNAH2 → ELAVL3 |
(<<) LYZL6 → ELAVL3 |
(<<) DEM1 → ELAVL3 |
(<<) SLC1A6 → ELAVL3 |
(<<) MATK → ELAVL3 |
Downstream (Children) |
---|
ELAVL3 → SIGLEC6 (>>) |
ELAVL3 → TRMT1 (>>) |
ELAVL3 → YBX1P2///YBX1 (>>) |
ELAVL3 → EMILIN2 (>>) |
ELAVL3 → DNAH2 (>>) |
ELAVL3 → KISS1 (>>) |
ELAVL3 → KCNA4 (>>) |
ELAVL3 → HOXD12 (>>) |
ELAVL3 → SLC1A6 (>>) |
ELAVL3 → MATK (>>) |